These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6979381)

  • 1. Chemotherapy of a malignant, metastasizing giant-cell tumor of bone: report of an unusual case and the response to combination chemotherapy.
    Mella O; Dahl O; Bang G; Engedal H; Gøthlin J; Lunde OD
    Cancer; 1982 Jul; 50(2):207-11. PubMed ID: 6979381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selected applications of methotrexate alone and in combination in osteosarcoma.
    Pratt CB
    Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age and dose of chemotherapy as major prognostic factors in a trial of adjuvant therapy of osteosarcoma combining two alternating drug combinations and early prophylactic lung irradiation. French Bone Tumor Study Group.
    Cancer; 1988 Apr; 61(7):1304-11. PubMed ID: 3125957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy of malignant fibrous histiocytoma of bone.
    Weiner M; Sedlis M; Johnston AD; Dick HM; Wolff JA
    Cancer; 1983 Jan; 51(1):25-9. PubMed ID: 6295593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
    Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
    Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy for osteosarcoma: a decade of experience.
    Goorin AM; Frei E; Abelson HT
    Surg Clin North Am; 1981 Dec; 61(6):1379-89. PubMed ID: 6976007
    [No Abstract]   [Full Text] [Related]  

  • 7. [Alternative chemotherapy of malignant bone neoplasms in children].
    Jurczyk-Procyk S; Perek D
    Probl Med Wieku Rozwoj; 1990; 16():55-68. PubMed ID: 1726893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.
    Rosen G; Marcove RC; Caparros B; Nirenberg A; Kosloff C; Huvos AG
    Cancer; 1979 Jun; 43(6):2163-77. PubMed ID: 88251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose methotrexate with leucovorin rescue plus vincristine in advanced sarcoma: a Southwest Oncology Group study.
    Vaughn CB; McKelvey E; Balcerzak SP; Loh K; Stephens R; Baker L
    Cancer Treat Rep; 1984 Feb; 68(2):409-10. PubMed ID: 6607770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic aspects of chemotherapy response in the treatment of osteogenic sarcoma. An analysis of two cases.
    Marroum MC; Huvos AG; Rosen G
    Oncology; 1977; 34(6):273-80. PubMed ID: 304199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer.
    Lamar RE; Greco FA; Johnson DH; Murphy PB; Hainsworth JD
    Cancer; 1994 Apr; 73(7):1842-8. PubMed ID: 8137208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of pulmonary metastases in children with osteogenic sarcoma with surgical resection combined with chemotherapy.
    Beattie EJ; Martini N; Rosen G
    Cancer; 1975 Mar; 35(3):618-21. PubMed ID: 1078639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy for extracranial metastases of a primary malignant cerebral neoplasm.
    Oster MW
    Cancer Treat Rep; 1979 Aug; 63(8):1417-8. PubMed ID: 476715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma.
    Rosen G; Tan C; Sanmaneechai A; Beattie EJ; Marcove R; Murphy ML
    Cancer; 1975 Mar; 35(3 suppl):936-45. PubMed ID: 1078642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.
    Jaffe N
    Cancer Chemother Rep; 1974; 58(2):275-80. PubMed ID: 4598245
    [No Abstract]   [Full Text] [Related]  

  • 16. [Course of metastatic osteogenic sarcoma treated with chemotherapy only (author's transl)].
    Tröger J; Gutjahr P
    Arch Orthop Trauma Surg (1978); 1979 Apr; 93(4):315-7. PubMed ID: 313774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
    Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR
    Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic basal cell carcinoma: report of a case responding to chemotherapy.
    Woods RL; Stewart JF
    Postgrad Med J; 1980 Apr; 56(654):272-3. PubMed ID: 6159619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.
    Rosen G; Caparros B; Huvos AG; Kosloff C; Nirenberg A; Cacavio A; Marcove RC; Lane JM; Mehta B; Urban C
    Cancer; 1982 Mar; 49(6):1221-30. PubMed ID: 6174200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The results of using high-dose methotrexate in treating osteogenic sarcoma].
    Perevodchikova NI; Eremina LA; Manziuk LV; Siniukov PA; Fedenko AN; Singin AS; Moldovanova LK
    Vopr Onkol; 1990; 36(6):667-71. PubMed ID: 2378085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.